Affibody‑mediated Imaging of EGFR Expression in Prostate Cancer Using Radiocobalt‑labeled DOTA‑ZEGFR:2377

Oncology Reports - Greece
doi 10.3892/or.2018.6792
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule 111In-Dota-Zigf1r:4551

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2011English

Affibody-Mediated PET Imaging of HER3 Expression in Malignant Tumours

Scientific Reports
Multidisciplinary
2015English

In Vivo and in Vitro Uptake of 111In, Delivered With the Affibody Molecule (ZEGFR:955)2, in EGFR Expressing Tumour Cells

Oncology Reports
MedicineCancer ResearchOncology
2008English

AEG-1 Promoter-Mediated Imaging of Prostate Cancer

Cancer Research
Cancer ResearchOncology
2014English

In Vivo Evaluation of a Radiogallium-Labeled Bifunctional Radiopharmaceutical, Ga-Dota-Mn2, for Hypoxic Tumor Imaging

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2013English

Cy5.5-Labeled Affibody Molecule for Near-Infrared Fluorescent Optical Imaging of Epidermal Growth Factor Receptor Positive Tumors

Journal of Biomedical Optics
ElectronicOpticsMolecular Physics,OpticalBiomaterialsAtomicMagnetic MaterialsBiomedical Engineering
2010English

First 18f-Labeled Ligand for PET Imaging of uPAR: In Vivo Studies in Human Prostate Cancer Xenografts

Nuclear Medicine and Biology
Cancer ResearchNuclear MedicineRadiologyMolecular MedicineImaging
2013English

Role of Imaging in Prostate Cancer

PET Clinics
MedicineNuclear MedicineRadiologyRadiationImaging
2009English

Full Preclinical Validation of the 123i-Labeled Anti-Psma Antibody Fragment ScFvD2B for Prostate Cancer Imaging

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy